Аналитика на 08.04.

Спайдер торгуется на премаркете около уровня сопротивления 155.50.

• Европейские индексы на положительной территории.
• Nikkei  +2,8 %

SPY (внутридневной график)  рост на премаркете. Сопротивление 155.50-156.00 Поддержка: 154.75 – 154.00



Ожидаемая макроэкономическая статистика:

• Нет значимых событий

Премаркет NYSE/NASDAQ:
Gappingup
 
In reaction to strong earnings/guidance: AZZ +0.4%.
M&A news: LUFK +37.3% (Lufkin Industries confirms it will be acquired by GE for $3.3 bln or $88.50/share in cash).
Select oil/gas related names showing strength boosted by LUFK news: WFT +2.2%, NBR +2%, OXY +1.1%.
Other news: BCRX +23.5% and NVAX +5%  (more reports of China bird flu deaths), BSDM +7.8% (announces exclusive multi-million dollar distribution agreement with Terumo Europe NV), TSL +6.4% (Trina Solar Chairman says company plans to return to profit in the second half of 2013, according to reports), AMRN +3.6% (announces new clinical data showing significant reductions in Apolipoprotein C-III levels in MARINE and ANCHOR Studies of Vascepa; Amarin's MARINE and ANCHOR trials, the 4 gram dose of Vascepa achieved reductions), CLF +3.5% (Barron's profiles positive view on Cliffs Natural Resources (CLF); mentions that company could become takeover target of valuation falls), STZ +3.3% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), CYMI +2.3% (Cymer: U.S. Department of Justice clears ASML acquisition of Cymer), SRPT +1.9% (still checking), BUD +1.6% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), AAPL +1.2% (still checking for anything specific), JPM +0.4% ( Dealbook discusss that JPM is working to prevent spilt of Chairman and CEO positions).
Analyst comments: RDN +2.5% (upgraded to Outperform from Neutral at Macquarie),-F and si WLL +2.1% (upgraded to Overweight from Neutral at JP Morgan), JNPR +2% (hearing upgraded to Buy from Hold at Argus), PERI +1.8% (initiated with a Buy at Needham based on strong product pipeline & valuation; tgt $14), NVS +0.9% (upgraded to Neutral from Underperform at BofA/Merril )
 
Gapping down
 
M&A news: OMPI -5.6% (Merz Pharma Group Withdraws Proposal to Acquire OMPI).
Select financial related names showing weakness: ING -1.4%, CS -1.3%, UBS -1.2%, HBC -0.6%.
Other news: CEDC -25% (won creditor approval of proposed restructuring plan), NBG -16.7% (following WSJ.com report suggesting Greek merger stopped), DCTH -6.2% (receives notification of PDUFA date extension), BYI -5% (still checking), YUM -0.7% (following news of new Chinese bird flu outbreak).
Analyst comments: JNJ -0.7% (downgraded to Neutral from Overweight at JP Morgan)
 
Торговые идеи NYSEи NASDAQ:
BBY – акция показывала силу в течении 2х дней. На премаркете торгуется у уровня сопротивления. Выше 25.50 смотрим акцию в лонг.
STZ – малообъемный премаркет, смотрим акцию в лонг выше 49.50.
BCRX – рост на новостях об эпидемии птичьего гриппа в Китае. Выше 2.00 смотрим акцию в лонг, ниже – шорт с потенциалом 25 центов.
YUM – шорт ниже 66.00 с потенциалом доллар и выше. Акция может быть волатильна на новостях об эпидемии в Китае.
 
Оригинал статьи: http://shark-traders.com/blog/analitika-na-08-04/